Biotage AB http://www.alacrastore.com/company-snapshot/Biotage_AB-2501696 Sunday, November 23, 2008 4:17:46 AM 2501696 Biotage AB en AlacraStore RSS Builder 1.0 30 SWEDEN - Qiagen NV agreed to acquire the Biosystems division of Biotage AB (BA), a biotechnology company, for an estimated ###.### mil Swedish krona ($## mil US). The transaction was to include a ##.#% stake in BA from Corbett Life Science Pty Ltd.10/2/2008 10:07:49 AMN7248227099NN7248226744FQiagen NVBiotage AB-Biosystems DivisionQiagen NVBiotage ABhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Qiagen_NV_acquires_Biotage_AB_Biosystems_Div_from_Biotage_AB-2016831040sdc/20168310402016831040Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqDrugsNetherlandsBiological products, except diagnostic substances2836FFForeignPublicQGEN2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizationsDrugsSwedenBiological products, except diagnostic substances2836FFForeignSubsidiary373085001Biotech coBiotechnology coCashCash OnlyAssets1044452001Oct 2 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000Qiagen NV, located in Venlo,Netherlands, is abiotechnology companyproviding pre-analyticalsample preparation of productsenabling genetic and proteinanalysis.Qiagen NV, located in Venlo, Netherlands, is a biotechnologycompany providing pre-analytical sample preparation ofproducts enabling genetic and protein analysis.Qiagen NV, located in Venlo, Netherlands, is a biotechnology company providing pre-analytical sample preparation of products enabling genetic and protein analysis.1.000002.000003.000004.00000Biosystems, located inUppsala, Sweden, providesgenetic analysis services viaits Pyrosequencing technology.Biosystems, located in Uppsala, Sweden, provides geneticanalysis services via its Pyrosequencing technology.Biosystems, located in Uppsala, Sweden, provides genetic analysis services via its Pyrosequencing technology.0.000000.000000.000000.00000YSwedish Krona01 Oct 08Wed, 01 Oct 2008 00:00:00 ESTDate Announced: 10/01/2008Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.00000367.979 Swedish Krona367.979000.00000367.979 Swedish Krona367.979000.000000.000000.000000.00000367.97900367.979 Swedish Krona0.14400N29.927000.000000.000000.000000.000000.0000053.0000053.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000SWEDEN - Qiagen NV agreed toacquire the Biosystemsdivision of Biotage AB (BA), abiotechnology company, for anestimated 367.979 mil Swedishkrona ($53 mil US). Thetransaction was to include a17.5% stake in BA from CorbettLife Science Pty Ltd.SWEDEN - Qiagen NV agreed to acquire the Biosystems division of Biotage AB (BA), a biotechnology company, for an estimated 367.979 mil Swedish krona ($53 mil US). The transaction was to include a 17.5% stake in BA from Corbett Life Science Pty Ltd.SWEDEN - Qiagen NV agreed to acquire the Biosystems division of Biotage AB (BA), abiotechnology company, for an estimated 367.979 mil Swedish krona ($53 mil US). Thetransaction was to include a 17.5% stake in BA from Corbett Life Science Pty Ltd.SWEDEN - Qiagen NV agreed to acquire the Biosystems division of Biotage AB (BA), a biotechnology company, for an estimated 367.979 mil Swedish krona ($53 mil US). The transaction was to include a17.5% stake in BA from Corbett Life Science Pty Ltd.SWEDEN - Qiagen NV agreed to acquire the Biosystems division of Biotage AB (BA), a biotechnology company, for an estimated 367.979 milSwedish krona ($53 mil US). The transaction was to include a 17.5% stake in BA from Corbett Life Science Pty Ltd.Greenhill & Co, LLC1.00000$ 53.000 - Greenhill & Co, LLC - Rep Sell0.00000Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations373085001NasdaqNetherlands2836ForeignPublicQGEN2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations849981001StockholmSweden2836ForeignPublicBIOTA53.00000367.9790053.0000029.92700Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/bir/805765bir/805765normBiotage ABSwedenServices: Production and marketing of systems for automated DNA sequencing and analysis73725112109DGBIOT6/14/2008 6:37:00 AM805765Company Profiles & FinancialsGale Company Profiles